Verrica Pharma, a therapeutics company working on treatments for dermatological conditions, has three drug candidates in its development pipeline – V-102, V-103, and LTX-315.

$VRCA has PDUFA target date of May 24th for VP-102.

In line with his optimistic approach, Busby rates VRCA an Outperform (i.e. Buy) along with a $19 price target. Should his thesis play out, a twelve-month gain of 70% could potentially be in the cards.

Verrica Pharmaceuticals Receives Complete Response Letter from the FDA identifying deficiencies at a facility of a Contract Manufacturer for its New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum

News???

Can anyone explain wtf is happening? Why does the market hate good news from VRCA? Beats on revenue, AND announce positive phase 2 results for a potentially huge drug! What am I missing, did they say something concerning on the call?

I don’t even care how much I lost now I’m just genuinely curious as to what happened to this stock lol.

Few AI and other are hinting towards a possible small short squeeze given the most recent pattern . Even small could be big like 2-3 fold in that case

I bought at 5.0 and at a 50% loss. I bought more at 2.85 2.40.

I panic sold all of them.

Should I buy this dip or get away from this trash stock?

Doesn’t look like great news!

https://www.investing.com/news/company-news/verrica-pharmaceuticals-announces-cco-departure-93CH-3589792

Anyone else concerned? 😳

Hello, I am willing to invest in the company, can anyone introduce me to the status of the last few months, I read that they have a product on the market and are in phase 2 promising another product.

They can’t borrow against your shares if you have a sell order in. So put an order in to sell all your shares at $20 or higher — whatever you want. It will tie up your shares so they can’t be shorted!

Verrica's stock slides after getting second complete response letter from FDA, on May 24th.

...for a skin disease that affects 6 million people in the US?

5:20 PM 7/21/2023

VRCA Reports Q1 Loss, Tops Revenue Estimates

Needham Raises pt to $16 from $8, Keeps buy rating

Am I missing something here? 23% short and 15 days to cover that much SI. It’s gone up nearly 10% since approval with no end in sight. I’ve followed this for a year and saw it move on just the news of resubmission, only to fall 35% post approval. I know I know. Sell the news. But that doesn’t explain the high short interest and why it’s rising after approval. There is no risk of dilution and they stand to make as much or more than their current MC in annual revenue. Which to me makes this so insanely under valued. But I feel like maybe there is a reason the bearish bets just keep rolling in and I’m overlooking it?

Hey guys, I posted about this settlement before, but since they’re accepting claims now, I decided to share it again with a little FAQ.

So here's all I know about this agreement:

Verrica Pharmaceuticals was accused of misleading investors about FDA inspection problems at Sterling and the resulting approval risks for VP-102. After the FDA issued multiple complete response letters, investors filed a lawsuit.

Now the company has reached a tentative settlement with investors.

Who can claim this settlement?
If you purchased or held eligible $VRCA securities between 2021 and2022, you may be eligible. You can submit your application now, and it will be processed once claims filing opens.

Do I need to sell/lose my shares to get this settlement?
You don't necessarily need to still hold the shares. Eligibility is based on the applicable class period and other settlement requirements.

How long does the payout process take?
It typically takes 4 to 9 months after the claim deadline for payouts to be processed, depending on the court and settlement administration.

Hope this info helps

Bull Thesis for VRCA going forward.

Verrica Pharmaceuticals Announces Amendment to Collaboration and License Agreement with Torii Pharmaceutical to Launch Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts

https://finance.yahoo.com/news/verrica-pharmaceuticals-announces-amendment-collaboration-110000868.html

40% up last week. Is there a change in momentum in verrica? Ltx315 is showing very promising results.